Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Ending TB-related stigma and discrimination.

Jaramillo E, Sahu S, Van Weezenbeek C.

Int J Tuberc Lung Dis. 2017 Nov 1;21(11):2-3. doi: 10.5588/ijtld.17.0229. No abstract available.

PMID:
29025478
2.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014. Review.

3.

Market size and sales pattern of tuberculosis drugs in the Philippines.

Islam T, van Weezenbeek C, Vianzon R, Garfin AM, Hiatt T, Lew WJ, Tisocki K.

Public Health Action. 2013 Dec 21;3(4):337-41. doi: 10.5588/pha.13.0094.

4.

Challenges to the global control of tuberculosis.

Chiang CY, Van Weezenbeek C, Mori T, Enarson DA.

Respirology. 2013 May;18(4):596-604. doi: 10.1111/resp.12067. Review.

5.

Multidrug resistance in new tuberculosis patients: burden and implications.

Royce S, Falzon D, van Weezenbeek C, Dara M, Hyder K, Hopewell P, Richardson MD, Zignol M.

Int J Tuberc Lung Dis. 2013 Apr;17(4):511-3. doi: 10.5588/ijtld.12.0286.

PMID:
23485384
6.

Supplemental Content

Loading ...
Support Center